Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial adenosine after successful thrombectomy for posterior circulation acute ischemic stroke
ChiCTR2500096821Phase 4Recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adenosine in ischemic stroke and brain infarction, sponsored by Southwest Hospital of Army Medical University. Primary endpoint: Proportion of participants with mRS 0-1 at 90 (+/-7) days. Started Feb 2025; status: recruiting.
02
Drugs
adenosine
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on ChiCTR2500096821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096821.